[HTML][HTML] DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Y Handelsman, JE Anderson, GL Bakris… - Metabolism, 2024 - Elsevier
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …
The impact of chronic obstructive pulmonary disease on the prognosis outcomes of patients with percutaneous coronary intervention or coronary artery bypass grafting …
Y Li, H Zheng, W Yan, N Cao, T Yan, H Zhu, H Bao - Heart & Lung, 2023 - Elsevier
Background Coronary artery disease (CAD) is one of the main types of cardiovascular
disease and is characterized by myocardial ischemia as a result of narrowing of the …
disease and is characterized by myocardial ischemia as a result of narrowing of the …
Impact of comorbidities in COPD clinical control criteria. The CLAVE study
P Almagro, JJ Soler-Cataluña, A Huerta… - BMC pulmonary …, 2024 - Springer
Background Chronic obstructive pulmonary disease (COPD) frequently coexists with other
chronic diseases, namely comorbidities. They negatively impact prognosis, exacerbations …
chronic diseases, namely comorbidities. They negatively impact prognosis, exacerbations …
Acute effects of fine particulate matter constituents on cardiopulmonary function in a panel of COPD patients
L Zhou, Y Tao, H Li, Y Niu, L Li, H Kan, J Xie… - Science of The Total …, 2021 - Elsevier
Background Exposure to fine particulate matter (PM 2.5) has been linked with adverse
cardiorespiratory health conditions. However, evidence for PM 2.5 constituents is still scarce …
cardiorespiratory health conditions. However, evidence for PM 2.5 constituents is still scarce …
Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy
A Papaporfyriou, K Bartziokas, D Gompelmann… - Life, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of
mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only …
mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only …
Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease
XF Li, CQ Wan, YM Mao - Frontiers in medicine, 2022 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) is a disease characterized by persistent
airflow limitation, and is associated with abnormal inflammatory responses in the lungs to …
airflow limitation, and is associated with abnormal inflammatory responses in the lungs to …
A nomogram for predicting in-stent restenosis risk in patients undergoing percutaneous coronary intervention: a population-based analysis
Y Luo, N Tan, J Zhao, Y Li - International Journal of General …, 2022 - Taylor & Francis
Objective In-stent restenosis (ISR) is a fatal complication of percutaneous coronary
intervention (PCI). An early predictive model with the medical history of patients …
intervention (PCI). An early predictive model with the medical history of patients …
Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease
A Casselbrant, A Fedorowski, S Frantz, G Engström… - Plos one, 2022 - journals.plos.org
Objective Chronic obstructive pulmonary disease (COPD) and coronary artery disease
(CAD) are leading causes of global morbidity and mortality. There is a well-known …
(CAD) are leading causes of global morbidity and mortality. There is a well-known …
Cardiovascular disease and risk in COPD: a state of the art review
ABSTRACT Introduction Chronic Obstructive Pulmonary Disease (COPD) and
cardiovascular diseases (CVD) commonly co-exist. Outcomes of people living with both …
cardiovascular diseases (CVD) commonly co-exist. Outcomes of people living with both …
[HTML][HTML] Pulmonary disease in diabetes
Z Bloomgarden - Journal of Diabetes, 2023 - ncbi.nlm.nih.gov
Diabetes is associated with a variety of pulmonary disorders beyond its associations with
sleep apnea discussed in the previous commentary. The Fremantle Diabetes Study in …
sleep apnea discussed in the previous commentary. The Fremantle Diabetes Study in …